Molecular Factors Influencing the Affinity of Flavonoid Compounds on P-Glycoprotein Efflux Transporter

被引:0
|
作者
Vazquez, Rodolfo N. [1 ,2 ]
Camargo, Alejandra B. [3 ,4 ,5 ]
Marchevsky, Eduardo J. [6 ,7 ]
Luco, Juan M. [1 ,2 ]
机构
[1] Univ Nacl San Luis, Fac Quim Bioquim & Farm, Dept Quim, RA-5700 Chacabuco, San Luis, Argentina
[2] Univ Nacl San Luis, Fac Quim Bioquim & Farm, Dept Quim, RA-5700 Pedernera, San Luis, Argentina
[3] Consejo Nacl Invest Cient & Tecn, IBAM, Mendoza, Argentina
[4] Univ Nacl Cuyo, Lab Cromatog Agroalimentos, Fac Ciencias Agr, RA-5505 Mendoza, Argentina
[5] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, RA-5505 Mendoza, Argentina
[6] Univ Nacl San Luis, Fac Quim Bioquim & Farm, Inst Quim San Luis INQUISAL, CONICET, RA-5700 Chacabuco, San Luis, Argentina
[7] Univ Nacl San Luis, Fac Quim Bioquim & Farm, Inst Quim San Luis INQUISAL, CONICET, RA-5700 Pedernera, San Luis, Argentina
关键词
Flavonoids; multivariate quantitative structure-activity relationships (QSARs); nonempirical descriptors; P-glycoprotein (Pgp); CELL MULTIDRUG-RESISTANCE; NUCLEOTIDE-BINDING DOMAIN; BLOOD-BRAIN-BARRIER; ABC TRANSPORTERS; DRUG ABSORPTION; INHIBITORS; CANCER; MECHANISMS; MODULATORS; CHALCONES;
D O I
10.2174/157340991003150302231140
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The most common mechanism of the so-called multidrug resistance (MDR), is mainly associated with an over expression of P-glycoprotein (Pgp). It is an ATP-dependent transport protein that limits the intracellular accumulation of a variety of structurally unrelated compounds within various organs and normal tissues such as kidney, small intestine and the blood brain barrier. Thus, the expression of Pgp has a major impact on the pharmacokinetic profile of many therapeutic agents and therefore, overcoming Pgp-mediated efflux constitutes an attractive means of potentially enhancing their therapeutic efficacy. The flavonoids comprise a large group of polyphenolic compounds that occur in plants and vegetables, and they have been shown to display a wide variety of biological activities. For example, anti-inflammatory, antioxidant, antiallergic, hepatoprotective, antithrombotic, antiviral, and anticarcinogenic activities. The interactions between flavonoids and Pgp have also been extensively studied and some quantitative structure-activity relationships (QSAR) have been reported. In the present work, we have employed 2D-QSAR analysis to evaluate the interactions between Pgp and several flavonoid compounds with the aim of identifying the molecular factors responsible for the Pgp-binding affinity evidenced by these compounds. Thus, the reported data for dissociation constants (KD) between Pgp and 62 flavonoid compounds were modeled by means of multiple regression analysis (MLR), and structures of the compounds under study were characterized by means of calculated physicochemical properties and several topological and constitutional descriptors, as well as geometrical and quantum chemical indexes. The obtained results suggest that the hydrophobic and especially geometric factors are of prime importance for binding, whereas in the case of flavonoid derivatives with flavone (flavonols), flavanone and isoflavone nuclei, the electronic factors are also involved in electron donor/acceptor interactions. In addition, in the case of chalcones, the results suggest that the affinity toward P-gp of such compounds is mainly governed by intermolecular dispersive interactions at the binding site.
引用
收藏
页码:250 / 258
页数:9
相关论文
共 50 条
  • [41] Interaction of the P-glycoprotein multidrug transporter with cholesterol
    Eckford, PDW
    Sharom, FJ
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 186A - 187A
  • [42] The reliability of molecular dynamics simulations of the multidrug transporter P-glycoprotein in a membrane environment
    Condic-Jurkic, Karmen
    Subramanian, Nandhitha
    Mark, Alan E.
    O'Mara, Megan L.
    PLOS ONE, 2018, 13 (01):
  • [43] Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-α-acetylmethadol, and paclitaxel
    Nekhayeva, Ilona A.
    Nanovskaya, Tatiana N.
    Hankins, Gary D. V.
    Ahmed, Mahmoud S.
    AMERICAN JOURNAL OF PERINATOLOGY, 2006, 23 (07) : 423 - 430
  • [44] Compartmental Models for Apical Efflux by P-glycoprotein: Part 2—A Theoretical Study on Transporter Kinetic Parameters
    Ken Korzekwa
    Swati Nagar
    Pharmaceutical Research, 2014, 31 : 335 - 346
  • [45] Effect of the Force Field on Molecular Dynamics Simulations of the Multidrug Efflux Protein P-Glycoprotein
    Wang, Lily
    O'Mara, Megan L.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2021, 17 (10) : 6491 - 6508
  • [46] Functional expression of a multidrug P-glycoprotein transporter of Leishmania
    Cortés-Selva, F
    Muñoz-Martínez, F
    Iliás, A
    Jiménez, AI
    Váradi, A
    Gamarro, F
    Castanys, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (02) : 502 - 507
  • [47] Non canonical functions of cellular transporter P-Glycoprotein
    Stavrovskaya, A. A.
    Moiseeve, N. I.
    BIOLOGICHESKIE MEMBRANY, 2016, 33 (05): : 323 - 334
  • [48] Bivalent probes of the human multidrug transporter P-glycoprotein
    Pires, Marcos M.
    Hrycyna, Christine A.
    Chmielewski, Jean
    BIOCHEMISTRY, 2006, 45 (38) : 11695 - 11702
  • [49] INTERACTION OF THE P-GLYCOPROTEIN MULTIDRUG TRANSPORTER WITH PEPTIDES AND IONOPHORES
    SHAROM, FJ
    DIDIODATO, G
    YU, XH
    ASHBOURNE, KJD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (17) : 10334 - 10341
  • [50] Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
    Stein, WD
    JOURNAL OF PHYSIOLOGY-LONDON, 1997, 499P : S21 - S21